Smoking, Tobacco Smoking
Conditions
Keywords
Tobacco Smoking, Cigarettes, Packaging, Text messaging, Graphic Images, Sensor-Based Assessments
Brief summary
The investigators are addressing two critical areas identified by the FDA: the impact of cigarette packaging and labeling on consumer perceptions and on smoking behavior; and the effectiveness of graphic warning labels on communicating risk of tobacco products. In a randomized controlled trial (RCT), investigators will enroll committed smokers who have no intention of quitting in the next 6-months. The three study arms will be: a) a blank pack with all marketing materials removed (PP); b) The Australian graphic warning images (Australian model-AM); or c) a standard pack with all marketing materials unaltered (ST). The study includes a three month purchasing intervention and continued follow-up through 12 months. Throughout the study interactive text messaging assessments will be used to measure acute and persistent impact of labeling and marketing on perceptions of tobacco products, subjective effects of consumption, awareness of tobacco-related harms, tobacco use behavior, and quitting motivation. At three separate time points, participants will: a) complete a web-based questionnaire b) provide a saliva sample for cotinine analysis. The rigorous design and extensive objective measurements are significant innovations on the currently published research in this field and should lead to significant advances in tobacco regulatory science.
Detailed description
Smokers handle their packs frequently. Product packaging is a crucial medium by which the tobacco industry communicates product attributes, including reassurances about risk. The industry uses branded imagery on packs to influence consumer perceptions of their product, while at the same time the tobacco control community uses health warning labels to communicate harmful and potentially harmful constituents and risks of tobacco products. The World Health Organization Framework Convention on Tobacco Control (WHO FCTC) is a treaty enacted to ensure that every person is informed of the health consequences and addictive nature of tobacco consumption. Article 11 of the treaty requires Parties to implement large, rotating health warnings and urges governments to restrict or prohibit the use of Industry logos, colors, brand images or promotional information on packaging other than brand names and product names displayed in a standard color and font style. Study Objective: To conduct a randomized trial of the effect of cigarette pack design on 450 smokers of popular cigarette brands aged 21-65, who are committed to continue smoking (no intention to quit in the next 6-months). These committed smokers will be randomized to have their cigarettes packaged in one of 3 study arms: a) blank pack design with all marketing materials removed (BP), b) blank pack with a large graphic warning label (AM: Australian model) and c) standard pack with marketing materials intact (ST: US model).
Interventions
The intervention is the use of the assigned pack design.
Sponsors
Study design
Eligibility
Inclusion criteria
* 21-65 years of age * A current resident of San Diego County * Daily smokers of at least 5 cigarettes/day who are classified as in the pre-contemplator stage of change (i.e. do not intend to quit smoking in the next 6-months) * Regular smokers of popular U.S. cigarette brands * Have a cell phone with a text messaging service plan
Exclusion criteria
* Non-Daily cigarette smokers and daily smokers of alternative brand cigarettes * Marked organic impairment or unstable medical problems (such as a seizure disorder) * Current pregnancy or intent to become pregnant during the next 12 weeks * Prisoners, incarcerated or institutionalized individuals
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Perceptions of Risk From Tobacco Use and Perceptions of Pack Appeal | Assessed over 4-months and 12-months | Changes in perceptions of risk from tobacco use and appeal of tobacco packs |
| Changes in Awareness and Concern about Health Hazards | Assessed over 4-months and 12-months | Changes in perceptions of harm and potential risks |
| Changes in routinized behavior and persistence over time. | Assessed over 4-months and 12-months | Decreased willingness to display the pack in public. |
| Changes in cigarette smoking behaviors. | Assessed over 4-months and 12-months | Changes in the percent smokers, consumption per smoker, and recent quit attempts validated with saliva cotinine. |
Countries
United States